Reldesemtiv is an investigational small molecule drug belonging to the class of fast skeletal muscle troponin activators (FSTAs), which function by sensitizing the sarcomere to calcium to increase muscle… Read more
Reldesemtiv is an investigational small molecule drug belonging to the class of fast skeletal muscle troponin activators (FSTAs), which function by sensitizing the sarcomere to calcium to increase muscle contractility. Designed as a potential therapeutic for conditions involving impaired muscle function and weakness, this compound is a subject of significant interest in preclinical and clinical research. This category provides access to essential Reldesemtiv reference standards, including stable isotope labelled compounds and related impurities. These high-quality materials are critical for pharmaceutical laboratories conducting comprehensive impurity profiling, method validation, and quality control. By utilizing these precisely characterized standards, analytical chemists can reliably identify trace impurities, support stability testing, and maintain rigorous accuracy in their experimental workflows throughout the development lifecycle of related neuromuscular therapeutics.